Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Huntsman

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Pathology|June 1, 2005
Podocalyxin: a marker of blasts in acute leukemiaTodd W Kelley, David Huntsman, Kelly M McNagny, et al.
Journal of the National Cancer Institute|September 8, 2005
Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSYAfshin Raouf, Lindsay Brown, Nikoleta Vrcelj, et al.
Pathology|August 30, 2008
Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patientsMichelle P Wong, Maggie Cheang, Erika Yorida, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2011
Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypesJefferson Terry, Alessandro De Luca, Samuel Leung, et al.
Journal of Pathology and Translational Medicine|August 29, 2020
Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridizationHezhen Ren, Jennifer Pors, Christine Chow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 16, 2020
Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the VulvaJennifer Pors, Basile Tessier-Cloutier, Emily Thompson, et al.
Clinical Breast Cancer|September 1, 2006
Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic diseaseAndrew G Robinson, Dmitry Turbin, Tom Thomson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancersWilliam J Lowery, Joellen M Schildkraut, Liudmila Akushevich, et al.
Genetic Testing|February 26, 2008
Predicting the performance of a genetic testing service for cancer susceptibilityChris D Bajdik, Steve Sung, John J Spinelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 17, 2012
Catenin family genes are not commonly mutated in hereditary diffuse gastric cancerJohanna M Schuetz, Stephen Leach, Pardeep Kaurah, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Pathology|June 1, 2005
Podocalyxin: a marker of blasts in acute leukemiaTodd W Kelley, David Huntsman, Kelly M McNagny, et al.
Journal of the National Cancer Institute|September 8, 2005
Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSYAfshin Raouf, Lindsay Brown, Nikoleta Vrcelj, et al.
Pathology|August 30, 2008
Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patientsMichelle P Wong, Maggie Cheang, Erika Yorida, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2011
Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypesJefferson Terry, Alessandro De Luca, Samuel Leung, et al.
Journal of Pathology and Translational Medicine|August 29, 2020
Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridizationHezhen Ren, Jennifer Pors, Christine Chow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 16, 2020
Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the VulvaJennifer Pors, Basile Tessier-Cloutier, Emily Thompson, et al.
Clinical Breast Cancer|September 1, 2006
Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic diseaseAndrew G Robinson, Dmitry Turbin, Tom Thomson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancersWilliam J Lowery, Joellen M Schildkraut, Liudmila Akushevich, et al.
Genetic Testing|February 26, 2008
Predicting the performance of a genetic testing service for cancer susceptibilityChris D Bajdik, Steve Sung, John J Spinelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 17, 2012
Catenin family genes are not commonly mutated in hereditary diffuse gastric cancerJohanna M Schuetz, Stephen Leach, Pardeep Kaurah, et al.
Pageof 15